6505--Metoprolol Succinate Tablets SA April 29, 2026 - April 28, 2027
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79725R0058
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its NAC Pharmaceuticals office, has issued an award notice for the procurement of Metoprolol Succinate Tablets, covering the period from April 29, 2026, to April 28, 2027. This procurement activity is classified under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating a focus on pharmaceutical products.
The primary objective of this contract is to ensure a reliable supply of Metoprolol Succinate Tablets for VA facilities, supporting the ongoing healthcare needs of veterans. Metoprolol Succinate is a widely used medication for managing cardiovascular conditions, and its availability is critical to the VA’s mission of providing comprehensive medical care to its beneficiaries. The scope of the contract encompasses the manufacturing and delivery of these pharmaceutical tablets in accordance with VA standards and requirements, with the expectation that the awarded supplier will maintain consistent quality, timely delivery, and compliance with all applicable regulatory guidelines throughout the contract lifecycle.
The contracting entity for this procurement is NAC Pharmaceuticals (36E797), a federal office within the Department of Veterans Affairs. The primary point of contact for this award is Matthew Poulin, who can be reached via email at [email protected] or by phone at 708-786-5186. Interested parties and stakeholders can access further details and documentation through the official notice posted on SAM.gov, using Opportunity ID 5c4f12c4ff384c6d854509d37d7cd338.
This award notice is currently active and was posted on September 1, 2026. While the notice does not specify set-aside requirements or special considerations, contractors should note that the procurement falls under the pharmaceutical manufacturing sector and is intended to support federal healthcare operations. The contract’s deliverables are expected to remain consistent throughout its duration, focusing on the supply of Metoprolol Succinate Tablets as specified by the VA.
Contractors evaluating this opportunity should consider their capacity to meet the VA’s stringent quality standards, regulatory compliance, and delivery schedules. The procurement represents a stable and ongoing requirement for pharmaceutical products within the federal healthcare system, offering a clear scope and defined outcomes aligned with the VA’s commitment to veteran care.